New Street Opioids, Their Mixtures and Emerging Interventions
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 10 February 2025 | Viewed by 211
Special Issue Editor
Special Issue Information
Dear Colleagues,
The emergence of new street opioids and their mixtures with other potent drugs has rendered the existing interventions and overdose prevention strategies less effective. High-potency opioids alone or in combination with novel and atypical substances have produced a multimodal respiratory depression and overdoses that are very challenging to reverse with any single agent. This new public emergency and unmet medical need require a prompt response from the research community to find an adequate pharmacological solution.
Therefore, the goal of this Special Issue is to define a landscape of the emerging interventions, pharmacological challenges, and potential synergetic approaches. Could vaccination against new street opioids be effective? Could a single opioid overdose reversal agent be effective under these circumstances? How do we bring these new therapies, especially combination therapies, from bench to bedside?
The Pharmaceuticals journal welcomes both reviews and original articles on the emerging therapies and pharmacology of the new street opioids. The manuscripts collected will be published as a Special Issue of this journal.
Dr. Michael V. Voronkov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fentanyl
- naloxone
- xylazine
- nitazenes
- opioid overdose
- addiction
- polypharmacology
- polypharmacy
- animal models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
